Abstract:Background: The intestinal mucosa is composed of a well-organized epithelium, acting as a physical barrier to harmful luminal contents, while simultaneously ensuring absorption of physiological nutrients and solutes. Increased intestinal permeability has been described in various chronic diseases, leading to abnormal activation of subepithelial immune cells and overproduction of inflammatory mediators. This review aimed to summarize and evaluate the effects of cytokines on intestinal permeability. Methods: A systematic review of the literature was performed in the Medline, Cochrane and Embase databases, up to 01/04/2022, to identify published studies assessing the direct effect of cytokines on intestinal permeability. We collected data on the study design, the method of assessment of intestinal permeability, the type of intervention and the subsequent effect on gut permeability. Results: A total of 120 publications were included, describing a total of 89 in vitro and 44 in vivo studies. TNFα, IFNγ or IL-1β were the most frequently studied cytokines, inducing an increase in intestinal permeability through a myosin light-chain-mediated mechanism. In situations associated with intestinal barrier disruption, such as inflammatory bowel diseases, in vivo studies showed that anti-TNFα treatment decreased intestinal permeability while achieving clinical recovery. In contrast to TNFα, IL-10 decreased permeability in conditions associated with intestinal hyperpermeability. For some cytokines (e.g. IL-17, IL-23), results are conflicting, with both an increase and a decrease in gut permeability reported, depending on the study model, methodology, or the studied conditions (e.g. burn injury, colitis, ischemia, sepsis). Conclusion: This systematic review provides evidence that intestinal permeability can be directly influenced by cytokines in numerous conditions. The immune environment probably plays an important role, given the variability of their effect, according to different conditions. A better understanding of these mechanisms could open new therapeutic perspectives for disorders associated with gut barrier dysfunction.

Gut Microbiota and Intestinal Trans-Epithelial Permeability

Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions

Border Control: The Role of the Microbiome in Regulating Epithelial Barrier Function

Paracellular permeability and tight junction regulation in gut health and disease

Microbial Metabolite Regulation of Epithelial Cell-Cell Interactions and Barrier Function

Cytokines and intestinal epithelial permeability: A systematic review

Epithelial integrity, junctional complexes, and biomarkers associated with intestinal functions

Intestinal mucosal barrier function in health and disease

Intestinal permeation and gastrointestinal disease

Intestinal Permeability, Inflammation and the Role of Nutrients

The diet-microbiota axis: a key regulator of intestinal permeability in human health and disease

Tight Junctions as a Key for Pathogens Invasion in Intestinal Epithelial Cells

Intestinal barrier: Molecular pathways and modifiers

Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier Function

Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier

Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease

The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation

Regulation of intestinal permeability: The role of proteases

Deciphering internal and external factors influencing intestinal junctional complexes

Overview of the Importance of Biotics in Gut Barrier Integrity

Integrity of the Intestinal Barrier: The Involvement of Epithelial Cells and Microbiota—A Mutual Relationship